The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: -108.00 (-0.87%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,362.00
Low: 12,250.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-German minister sees COVID-19 vaccine shortage well into April

Thu, 28th Jan 2021 08:55

* Health minister: vaccine shortages to last at least 10
weeks

* Interior ministry preparing entry ban for risk countries

* 7-day incidence falls below 100 cases/100,000 people
(Adds details on incidence, entry ban)

BERLIN, Jan 28 (Reuters) - Germany faces a shortage of
coronavirus shots well into April, its health minister said on
Thursday, and called for a summit with the country's state
leaders to discuss vaccinations as the government faced fresh
criticism over the pace of the roll-out.

"We will still have at least 10 tough weeks with a shortage
of vaccine," Jens Spahn said in a Tweet, adding the meeting
should focus on how Europe gets its fair share of shots and what
can be done to support the process.

A spokesman for Chancellor Angela Merkel said she backed the
proposal and planning for the summit was already underway.

On Thursday, Germany's top-selling Bild newspaper described
the problem of procuring enough vaccines as a "scandal," while a
poll for the Frankfurter Allgemeine Zeitung said approval for
the government's coronavirus policy had fallen to 49%, its
lowest level since the pandemic began.

Spahn said he wanted to invite pharmaceutical companies and
vaccine manufacturers to a meeting to discuss the way forward,
adding he recognised vaccine production was complex and
production could not be built up in a few weeks.

On Tuesday, Spahn supported European Union proposals to set
up a register of vaccine exports, as tensions grow with
AstraZeneca and Pfizer over sudden supply cuts
just a month after the EU started vaccinating citizens.

Germany reported 17,553 new coronavirus cases on Thursday,
bringing the total to 2,178,828, and another 941 deaths. The
seven-day incidence rate fell under 100 cases per 100,000 for
the first time since the end of October. The government wants it
to drop below 50.

Spahn has said that if cases continue to fall, schools and
nurseries should be the first to reopen after a lockdown
currently due to last until Feb. 14.

Germany is also preparing entry restrictions for travellers
from Britain, Brazil and South Africa, the interior ministry
said, and hopes to decide by Friday as concerns mount about more
contagious variants.

"We have to get ahead of the situation," Interior Minister
Horst Seehofer said on Twitter.
(Reporting by Emma Thomasson, Caroline Copley and Andreas
Rinke; Editing by Thomas Seythal, Alex Richardson and Giles
Elgood)

More News
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.